There is a point where a low-budget horror film stops being a surprise and becomes a market force. Focus Features’ Obsession crossed that threshold weeks ago. As of June 3, the Curry Barker-directed thriller has grossed roughly $116.8 million domestically and $161.5 million worldwide, all on a production budget that sits somewhere between $750,000 and $1 million according to production records. Those returns are no longer just impressive; they are historically anomalous for a theatrical debut this small.
The film’s third weekend, which covered May 29 through May 31, delivered an estimated $26.4 million to $27.4 million. That figure represents a jump of roughly 10 to 14 percent from the previous frame, a directional move that defies every modern theatrical rulebook. Bloody Disgusting confirmed the milestone: Obsession is the first wide release since E.T. the Extra-Terrestrial in 1982 to record three consecutive weekends of increasing grosses. In an era when most tentpoles hemorrhage 50 percent or more in their sophomore sessions, a micro-budget feature is walking uphill while blockbuster slides slide down.
The achievement has already reshaped the record books for its distributor. By its third weekend, Obsession had sailed past Downton Abbey to become the highest-grossing domestic release in Focus Features history. That is a remarkable statement for a label built on prestige dramas and acquired specialties. A supernatural psychological horror title shot on a shoestring is now the commercial standard-bearer for the studio, and it reached that summit without the benefit of a built-in franchise or household name above the title.
Audiences are not showing signs of fatigue. Daily grosses through early June have held firm, and exhibitors have scheduled showtimes deep into mid-June. The sustained demand forced an unusual reversal: the digital release that was slated for June 2 has been pulled from the calendar indefinitely. Focus Features is effectively admitting that the theatrical runway still has juice, a decision that cuts against the prevailing industry instinct to rush films onto premium video-on-demand within weeks of opening. When a movie costs less than a single episode of a streaming drama and is still pulling eight-figure weekends, there is no reason to kill the golden goose.
The timing places Obsession in direct conversation with another indie horror phenomenon, A24’s Backrooms, which just posted the largest opening ever for an original horror property. While Backrooms dominated headlines with its explosive debut, Barker’s film has proven that stamina can rival spectacle. The two releases have created a rare dual boom for low-budget horror, a dynamic we explored as both titles began their theatrical swarm earlier this spring. Where Backrooms shattered records out of the gate, Obsession is demonstrating that word-of-mouth momentum can engineer a months-long theatrical life.
Industry metrics underline just how extreme the performance is. Collider noted that the film has already earned more than 140 times its production budget, a multiple that renders most Hollywood accounting irrelevant. For context, major franchise entries often need $500 million or more in global receipts just to turn a profit after marketing and distribution costs. Obsession likely hit profitability before its second weekend concluded, and every ticket sold now is essentially margin.
What happens next is almost uncharted. The studio has not set a new digital date, and theater chains appear happy to keep the screen real estate. With Toy Story 5 entering the marketplace later this month, some compaction is inevitable, but Obsession has already outlasted most summer releases that arrived with ten times its marketing spend. Even Backrooms, for all its historic firepower, may find itself looking at Obsession as the model for longevity rather than launch velocity.
The broader implication is hard to ignore. Distributors have spent years arguing that mid-budget and micro-budget films belong on streaming, where algorithmic placement might recoup modest investments. Obsession stands as a blunt counterargument. It was built for theaters, discovered by audiences in theaters, and is now being withheld from digital platforms because theaters remain the most lucrative venue. If a $1 million feature can outgross global blockbusters on a per-dollar basis and force a studio to cancel its own streaming transition, the next round of indie financing might look less like a Netflix acquisition and more like a limited theatrical run with real legs. Barker did not just make a horror hit. He made a case for the big screen that the industry cannot afford to dismiss.
